AIM Vaccine Co., Ltd. SARS-CoV-2 mRNA vaccine

· AIM Vaccine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AIM Vaccine Co., Ltd. SARS-CoV-2 mRNA vaccine, covering 2023-09-06 to 2023-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People [Phase 2]